Berotralstat

Records for this ingredient, by country (identity only).

ATC B06AC06 · 7 markets · 12 records

Berotralstat 7 markets · 12 records Forms
Filters
MarketUS 6GB 1CA 1ES 1JP 1EU 1FR 1

US 6 records · 6 shown of 6 Source openFDA NDC Directory · Data as of 2026-10-23

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

ES 1 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

JP 1 records · 1 shown of 1 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

  • 150 mgcapsuleオラデオカプセル150mg also in US·GB·CA
    +2Other 2 marketsESFR

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Orladeyo ×3

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

  • 150 mgcapsuleORLADEYO 150 mg, gélule also in US·GB·CA
    +2Other 2 marketsESJP
The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.